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SUMMARY. Inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 have been used as tools
for the screening of anti-inflammatory agents. In a search for inhibitors of COX-2 and iNOS, we found
that extracts of Enteromorpha prolifera inhibit the production of nitric oxide (NO) and prostaglandin
(PG)E2 in LPS-stimulated RAW 264.7 macrophage cells. We first extracted E. prolifera with 80% ethanol
and the extract was partitioned with hexane, dichloromethane, ethyl acetate, butanol, and water, succes-
sively. The results indicate that the hexane and ethyl acetate fractions effective inhibited LPS-induced NO
and PGE2 production in RAW 264.7 cells. To test the inhibition effects of the E. prolifera fractions on oth-
er cytokines, we also performed an ELISA assay on tumor necrosis factor (TNF)-α, IL-1β, and IL-6 in
LPS-stimulated RAW 264.7 macrophage cells. The expression of TNF-α, IL-1β, and IL-6 was also de-
creased following treatment with the hexane and ethyl acetate fractions. To test the potential application
of the E. prolifera extract as a cosmetic material, we also performed MTT assays on keratinocyte HaCaT
cells as well as primary skin irritation tests. In these assays, the E. prolifera extracts did not induce any ad-
verse reactions. Based on these results, we suggest that E. prolifera extracts may be considered potential
anti-inflammatory candidates for skin health. 
